Axogen Inc (AXGN)
Axogen is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Co.'s platform for peripheral nerve repair features a portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; and Axoguard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Co. also provides Axotouch Two-Point Discriminator, which is used to measure the innervation density of any surface area of the skin.
AXGN SEC Filing Email Alerts Service
| Company Name: |
Axogen Inc |
| Website: |
www.axogeninc.com |
| Sector: |
Medical Instruments & Supplies |
| Number of ETFs Holding AXGN: |
15 |
| Total Market Value Held by ETFs: |
$27.08M |
| Total Market Capitalization: |
$312.00M |
| % of Market Cap. Held by ETFs: |
8.68% |
|
|
April 16, 2024 • 12:08 PM Eastern
Strong Buy (4.00 out of 4)
100th percentile
|
|
Free AXGN Email Alerts:
